SEI INVESTMENTS CO - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,329,066
+1.7%
307,655
+55.2%
0.00%0.0%
Q2 2023$1,306,742
+1.0%
198,292
+4.1%
0.00%0.0%
Q1 2023$1,293,445
-9.6%
190,492
-1.6%
0.00%
-33.3%
Q4 2022$1,431,115
+4.3%
193,655
+39.5%
0.00%0.0%
Q3 2022$1,372,000
+170.6%
138,847
+198.5%
0.00%
+200.0%
Q2 2022$507,000
-63.7%
46,518
-62.3%
0.00%
-66.7%
Q1 2022$1,396,000
-29.9%
123,478
-2.7%
0.00%
-25.0%
Q4 2021$1,991,000
-39.4%
126,912
-33.8%
0.00%
-42.9%
Q3 2021$3,286,000
-23.5%
191,770
-4.3%
0.01%
-30.0%
Q2 2021$4,296,000
+79.6%
200,418
+23.9%
0.01%
+66.7%
Q1 2021$2,392,000
+16.9%
161,794
+2.5%
0.01%
+20.0%
Q4 2020$2,046,000
+56.5%
157,822
+14.4%
0.01%
+25.0%
Q3 2020$1,307,000
+3.3%
137,913
+24.4%
0.00%0.0%
Q2 2020$1,265,000
+10.4%
110,880
+0.3%
0.00%0.0%
Q1 2020$1,146,000
-66.1%
110,598
-46.3%
0.00%
-60.0%
Q4 2019$3,381,000
+30.5%
206,055
+5.6%
0.01%
+42.9%
Q3 2019$2,591,000
+1.8%
195,124
+8.1%
0.01%
-12.5%
Q2 2019$2,544,000
-19.4%
180,520
+5.0%
0.01%
-27.3%
Q1 2019$3,158,000
-18.9%
171,892
+4.0%
0.01%
-21.4%
Q4 2018$3,894,000
+26.4%
165,327
+23.2%
0.01%
+27.3%
Q3 2018$3,080,000
+80.5%
134,196
+49.9%
0.01%
+83.3%
Q2 2018$1,706,000
-61.6%
89,510
-66.1%
0.01%
-64.7%
Q1 2018$4,448,000
+5.6%
263,959
-4.7%
0.02%
+13.3%
Q4 2017$4,212,000
-12.1%
277,088
+3.5%
0.02%
-11.8%
Q3 2017$4,792,000
+17014.3%
267,671
+15516.7%
0.02%
Q2 2017$28,000
+115.4%
1,714
+81.2%
0.00%
Q1 2017$13,0000.0%946
+15.9%
0.00%
Q4 2016$13,000
-95.9%
816
-97.1%
0.00%
-100.0%
Q3 2015$319,00028,2680.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders